足白癬治療の世界市場レポート 2025年

足白癬治療市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.0％で18億3,000万米ドルに成長します。予測期間の成長は、世界化、旅行、薬剤耐性、経済的要因、公衆衛生キャンペーンに起因すると考えられます。予測期間の主な動向には、革新的ドラッグデリバリーシステム、医療の進歩、製薬技術の進歩、ナノテクノロジーなどがあります。

足と足首の怪我の頻度の増加が、今後数年間の足白癬治療市場の拡大を牽引する見通しです。足や足首の怪我は、足や足首の骨、靭帯、腱、筋肉、その他の組織の損傷や外傷を包含し、事故やスポーツ活動、反復的なストレスによって生じることが多いです。ライフスタイルの変化、スポーツや身体活動への参加の増加、不適切な靴、誤ったトレーニング方法、転倒しやすい体質、変性疾患など、さまざまな要因が足や足首の傷害の原因となっています。さらに、肥満や糖尿病などの慢性疾患の蔓延は、足や足首の合併症のリスクを高めています。このような怪我は、真菌の繁殖を助長し、運動不足の期間を長引かせることで、足白癬治療を悪化させる可能性があります。例えば、2023年11月、Howden Group Holdings Ltdは、FIFAワールドカップ・カタール2022年大会後の2022年10月から2023年1月にかけて、イングランド・プレミアリーグにおける足首の怪我の重症度が170％増加したと報告しています。したがって、足と足首の怪我の発生率の上昇が足白癬治療市場を推進しています。

真菌感染症の罹患率の増加は、今後数年間の足白癬治療市場の拡大を促進すると予想されます。真菌感染症は真菌によって引き起こされる疾患で、身体のさまざまな部分に影響を及ぼす可能性があります。真菌感染症の増加は、免疫力の低下、真菌の増殖を促進する環境条件、真菌への暴露、基礎的な健康状態、職業的リスク、衛生習慣などの要因に起因しています。足白癬治療では、真菌感染症を除去し、それに伴う症状を緩和することに焦点を当てています。例えば、2024年1月、英国の政府機関であるUK Health Security Agencyは、2022年に英国で血流感染症例が6.0％増加したと報告しました。さらに、同年に報告された1万6,643件の抗生物質耐性血流感染症のうち、82％を大腸菌が占めていました。その結果、真菌感染症の有病率の増加が足白癬治療市場の成長に拍車をかけています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界足白癬治療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の足白癬治療市場：成長率分析
• 世界の足白癬治療市場の実績：規模と成長, 2019-2024
• 世界の足白癬治療市場の予測：規模と成長, 2024-2029, 2034F
• 世界足白癬治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の足白癬治療市場薬剤クラス別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗真菌薬
• 組み合わせ
• 世界の足白癬治療市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オーラル
• トピック
• 世界の足白癬治療市場：疾患適応症別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 趾間白癬
• 足底白癬
• 水疱性足白癬
• 世界の足白癬治療市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• eコマース
• 世界の足白癬治療市場抗真菌薬の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 局所抗真菌薬
• 経口抗真菌薬
• 世界の足白癬治療市場、組み合わせのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗真菌薬とコルチコステロイドの併用
• 抗真菌剤と消毒剤の組み合わせ

第7章 地域別・国別分析

• 世界の足白癬治療市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の足白癬治療市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 足白癬治療市場：競合情勢
• 足白癬治療市場：企業プロファイル
  • McKesson Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Sandoz International GmbH
• Bausch Health Companies Inc.
• Perrigo Company plc
• Aurobindo Pharma
• Dr. Reddy's Laboratories Ltd.
• Cipla Ltd.
• Lupin Limited
• Glenmark Pharmaceuticals Ltd.
• Almirall S.A.
• Exeltis USA Inc.
• Taro Pharmaceutical Industries Ltd.
• Tolmar Pharmaceuticals Inc.
• Sebela Pharmaceuticals Inc.
• Ego Pharmaceuticals Pty. Ltd.
• Fougera Pharmaceuticals Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 足白癬治療市場2029：新たな機会を提供する国
• 足白癬治療市場2029：新たな機会を提供するセグメント
• 足白癬治療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Tinea pedis treatment encompasses various medical interventions and self-care practices aimed at alleviating symptoms and eradicating the fungal infection known as athlete's foot. Antifungal drugs, available in both topical and oral forms, are commonly utilized to eliminate the fungus causing the infection and reduce symptoms such as itching, redness, and inflammation, thereby preventing the spread of the infection to other parts of the body.

The primary drug classes used in tinea pedis treatment include antifungals and combinations. Antifungals are substances or medications specifically designed to kill or inhibit the growth of fungi responsible for tinea pedis. They can be administered orally or topically to treat interdigital tinea pedis, plantar tinea pedis, and vesicular tinea pedis indications. These medications are distributed through various channels including hospital pharmacies, retail pharmacies, and e-commerce platforms.

The tinea pedis treatment market research report is one of a series of new reports from The Business Research Company that provides tinea pedis treatment market statistics, including tinea pedis treatment industry global market size, regional shares, competitors with a tinea pedis treatment market share, detailed tinea pedis treatment market segments, market trends and opportunities, and any further data you may need to thrive in the tinea pedis treatment industry. This tinea pedis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The tinea pedis treatment market size has grown strongly in recent years. It will grow from $1.36 billion in 2024 to $1.45 billion in 2025 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to rising incidence of infectious disorders, ancient remedies, discovery of Antifungals, Over-the-Counter (OTC) Products and medical education.

The tinea pedis treatment market size is expected to see strong growth in the next few years. It will grow to $1.83 billion in 2029 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to globalization, travel, drug resistance, economic factors and public health campaigns. Major trends in the forecast period include Innovative drug delivery systems, medical advancements, advancements in pharmaceutical technology and nanotechnology.

The increasing frequency of foot and ankle injuries is poised to drive the expansion of the tinea pedis treatment market in the coming years. Foot and ankle injuries encompass damage or trauma to the bones, ligaments, tendons, muscles, or other tissues in the foot or ankle area, often resulting from accidents, sports activities, or repetitive stress. Various factors, including changes in lifestyle, heightened participation in sports and physical activities, improper footwear, incorrect training methods, susceptibility to falls, and degenerative conditions, contribute to foot and ankle injuries. Additionally, the prevalence of obesity and chronic diseases such as diabetes heightens the risk of foot and ankle complications. Such injuries can exacerbate tinea pedis treatment by creating conducive conditions for fungal growth and prolonging periods of inactivity. For instance, in November 2023, Howden Group Holdings Ltd reported a 170% increase in the severity of ankle injuries in the English Premier League from October 2022 to January 2023 following the FIFA World Cup Qatar 2022. Therefore, the rising incidence of foot and ankle injuries propels the tinea pedis treatment market.

The growing incidence of fungal infections is expected to drive the expansion of the tinea pedis treatment market in the coming years. Fungal infections are diseases caused by fungi that can affect various parts of the body. The rise in fungal infections is attributed to factors such as weakened immune systems, environmental conditions that promote fungal growth, exposure to fungi, underlying health conditions, occupational risks, and hygiene practices. Tinea pedis treatment focuses on eliminating the fungal infection and alleviating the symptoms associated with it. For example, in January 2024, the UK Health Security Agency, a UK-based government agency, reported a 6.0% increase in bloodstream infection cases in England in 2022. Additionally, E. coli was responsible for 82% of the 16,643 antibiotic-resistant bloodstream infections reported in the same year. As a result, the increasing prevalence of fungal infections is fueling the growth of the tinea pedis treatment market.

Major players in the tinea pedis treatment market are developing comprehensive formulations for controlling skin infections, aiming to improve patient outcomes. These formulations provide holistic solutions by addressing the fungal infection, preventing its recurrence, and managing associated symptoms such as itching, scaling, and redness. For example, in May 2022, Bayer, a pharmaceutical company based in Germany, introduced an innovative and enhanced line of Canesten products. These formulations effectively alleviate itching and hinder the further spread of infection. Canesten cream offers relief for conditions such as ringworm, jock itch, athlete's foot, skin candidiasis, erythrasma, and various fungal infections. With clotrimazole as the active ingredient, it targets the fungal infection responsible for athlete's foot. Clotrimazole disrupts fungal growth, thus alleviating symptoms such as itching, burning, and skin irritation commonly associated with tinea pedis.

Major companies operating in the tinea pedis treatment market are McKesson Corporation, Pfizer Inc., Bayer AG, Novartis AG, GlaxoSmithKline plc, Sandoz International GmbH, Bausch Health Companies Inc., Perrigo Company plc, Aurobindo Pharma, Dr. Reddy's Laboratories Ltd., Cipla Ltd., Lupin Limited, Glenmark Pharmaceuticals Ltd., Almirall S.A., Exeltis USA Inc., Taro Pharmaceutical Industries Ltd., Tolmar Pharmaceuticals Inc., Sebela Pharmaceuticals Inc., Ego Pharmaceuticals Pty. Ltd., Fougera Pharmaceuticals Inc., Camber Pharmaceuticals Inc, Mayne Pharma Group Limited, Sun Pharmaceutical Industries Ltd., CorePharma LLC, Blueberry Therapeutics Ltd.

North America was the largest region in the tinea pedis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tinea pedis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the tinea pedis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The tinea pedis treatment market consists of revenues earned by entities by providing services such as self-care measures, over-the-counter antifungal medications, prescription-strength medications, education and prevention. The market value includes the value of related goods sold by the service provider or included within the service offering. The tinea pedis treatment market also includes sales of antifungal medications, steroid creams, powders, sprays. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tinea Pedis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tinea pedis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tinea pedis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The tinea pedis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Drug Class: Antifungals; Combinations
• 2) By Route of Administration: Oral; Topical
• 3) By Disease Indication: Interdigital Tinea Pedis; Plantar Tinea pedis; Vesicular Tinea Pedis
• 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; E-commerce
• Subsegments:
• 1) By Antifungals: Topical Antifungal Drugs; Oral Antifungal Drugs
• 2) By Combinations: Antifungal And Corticosteroid Combinations; Antifungal And Antiseptic Combinations
• Companies Mentioned: McKesson Corporation; Pfizer Inc.; Bayer AG; Novartis AG; GlaxoSmithKline plc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Tinea Pedis Treatment Market Characteristics

3. Tinea Pedis Treatment Market Trends And Strategies

4. Tinea Pedis Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Tinea Pedis Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Tinea Pedis Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Tinea Pedis Treatment Market Growth Rate Analysis
• 5.4. Global Tinea Pedis Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Tinea Pedis Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Tinea Pedis Treatment Total Addressable Market (TAM)

6. Tinea Pedis Treatment Market Segmentation

• 6.1. Global Tinea Pedis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antifungals
• Combinations
• 6.2. Global Tinea Pedis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Topical
• 6.3. Global Tinea Pedis Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Interdigital Tinea Pedis
• Plantar Tinea Pedis
• Vesicular Tinea Pedis
• 6.4. Global Tinea Pedis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• E-commerce
• 6.5. Global Tinea Pedis Treatment Market, Sub-Segmentation Of Antifungals, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Topical Antifungal Drugs
• Oral Antifungal Drugs
• 6.6. Global Tinea Pedis Treatment Market, Sub-Segmentation Of Combinations, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antifungal And Corticosteroid Combinations
• Antifungal And Antiseptic Combinations

7. Tinea Pedis Treatment Market Regional And Country Analysis

• 7.1. Global Tinea Pedis Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Tinea Pedis Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Tinea Pedis Treatment Market

• 8.1. Asia-Pacific Tinea Pedis Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Tinea Pedis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Tinea Pedis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Tinea Pedis Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Tinea Pedis Treatment Market

• 9.1. China Tinea Pedis Treatment Market Overview
• 9.2. China Tinea Pedis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Tinea Pedis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Tinea Pedis Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Tinea Pedis Treatment Market

• 10.1. India Tinea Pedis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Tinea Pedis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Tinea Pedis Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Tinea Pedis Treatment Market

• 11.1. Japan Tinea Pedis Treatment Market Overview
• 11.2. Japan Tinea Pedis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Tinea Pedis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Tinea Pedis Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Tinea Pedis Treatment Market

• 12.1. Australia Tinea Pedis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Tinea Pedis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Tinea Pedis Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Tinea Pedis Treatment Market

• 13.1. Indonesia Tinea Pedis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Tinea Pedis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Tinea Pedis Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Tinea Pedis Treatment Market

• 14.1. South Korea Tinea Pedis Treatment Market Overview
• 14.2. South Korea Tinea Pedis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Tinea Pedis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Tinea Pedis Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Tinea Pedis Treatment Market

• 15.1. Western Europe Tinea Pedis Treatment Market Overview
• 15.2. Western Europe Tinea Pedis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Tinea Pedis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Tinea Pedis Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Tinea Pedis Treatment Market

• 16.1. UK Tinea Pedis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Tinea Pedis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Tinea Pedis Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Tinea Pedis Treatment Market

• 17.1. Germany Tinea Pedis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Tinea Pedis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Tinea Pedis Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Tinea Pedis Treatment Market

• 18.1. France Tinea Pedis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Tinea Pedis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Tinea Pedis Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Tinea Pedis Treatment Market

• 19.1. Italy Tinea Pedis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Tinea Pedis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Tinea Pedis Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Tinea Pedis Treatment Market

• 20.1. Spain Tinea Pedis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Tinea Pedis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Tinea Pedis Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Tinea Pedis Treatment Market

• 21.1. Eastern Europe Tinea Pedis Treatment Market Overview
• 21.2. Eastern Europe Tinea Pedis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Tinea Pedis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Tinea Pedis Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Tinea Pedis Treatment Market

• 22.1. Russia Tinea Pedis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Tinea Pedis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Tinea Pedis Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Tinea Pedis Treatment Market

• 23.1. North America Tinea Pedis Treatment Market Overview
• 23.2. North America Tinea Pedis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Tinea Pedis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Tinea Pedis Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Tinea Pedis Treatment Market

• 24.1. USA Tinea Pedis Treatment Market Overview
• 24.2. USA Tinea Pedis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Tinea Pedis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Tinea Pedis Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Tinea Pedis Treatment Market

• 25.1. Canada Tinea Pedis Treatment Market Overview
• 25.2. Canada Tinea Pedis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Tinea Pedis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Tinea Pedis Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Tinea Pedis Treatment Market

• 26.1. South America Tinea Pedis Treatment Market Overview
• 26.2. South America Tinea Pedis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Tinea Pedis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Tinea Pedis Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Tinea Pedis Treatment Market

• 27.1. Brazil Tinea Pedis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Tinea Pedis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Tinea Pedis Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Tinea Pedis Treatment Market

• 28.1. Middle East Tinea Pedis Treatment Market Overview
• 28.2. Middle East Tinea Pedis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Tinea Pedis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Tinea Pedis Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Tinea Pedis Treatment Market

• 29.1. Africa Tinea Pedis Treatment Market Overview
• 29.2. Africa Tinea Pedis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Tinea Pedis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Tinea Pedis Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Tinea Pedis Treatment Market Competitive Landscape And Company Profiles

• 30.1. Tinea Pedis Treatment Market Competitive Landscape
• 30.2. Tinea Pedis Treatment Market Company Profiles
  • 30.2.1. McKesson Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

31. Tinea Pedis Treatment Market Other Major And Innovative Companies

• 31.1. Sandoz International GmbH
• 31.2. Bausch Health Companies Inc.
• 31.3. Perrigo Company plc
• 31.4. Aurobindo Pharma
• 31.5. Dr. Reddy's Laboratories Ltd.
• 31.6. Cipla Ltd.
• 31.7. Lupin Limited
• 31.8. Glenmark Pharmaceuticals Ltd.
• 31.9. Almirall S.A.
• 31.10. Exeltis USA Inc.
• 31.11. Taro Pharmaceutical Industries Ltd.
• 31.12. Tolmar Pharmaceuticals Inc.
• 31.13. Sebela Pharmaceuticals Inc.
• 31.14. Ego Pharmaceuticals Pty. Ltd.
• 31.15. Fougera Pharmaceuticals Inc.

32. Global Tinea Pedis Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Tinea Pedis Treatment Market

34. Recent Developments In The Tinea Pedis Treatment Market

35. Tinea Pedis Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Tinea Pedis Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Tinea Pedis Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Tinea Pedis Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer